C.Q. Pharmaceutical Hits Day Low of CNY 5.33 Amid Price Pressure

C.Q. Pharmaceutical Holding Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 5.5% on July 17, 2026, reaching an intraday low of CNY 5.33. This performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Despite the day's downturn, C.Q. Pharmaceutical has shown resilience over the past week, with a gain of 2.9%, outperforming the Shanghai Composite, which dropped by 5.81%. Over the past month, the stock has also maintained a positive trajectory, up 2.7%, while the index has declined by 8.37%. Financially, C.Q. Pharmaceutical holds a market capitalization of CNY 9,488 million and a price-to-earnings ratio of 17.00. The company boasts a return on equity of 4.69% and a price-to-book ratio of 0.81, indicating an attractive valuation. Additionally, it offers a dividend yield of 1.09%, reflecting its commitment to returning value to shareholders.